Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 190articles · 30d
- 2+ hour agolatest article
- Aug 17, 2026earliest in window
- 89%with images
- 244avg words
- Medical 137
- Health & Wellness 101
- Economy, Business & Finance 83
- Health 74
- Business & Industrial 68
- Finance & Business 35
- Science & Technology 21
- News 14
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate
4+ day, 21+ hour ago (88+ words) Indian Pharma Post Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device assessment for ACT-101, supporting Aceso’s clinical development roadmap Chasing Consistency:…...
Superluminal Medicines raises $60 million to push obesity drug into clinic
5+ day, 22+ hour ago (62+ words) Indian Pharma Post Superluminal Medicines raises $60 million to push obesity drug into clinic Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The complexity of compliance The…...
Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial
1+ week, 17+ hour ago (68+ words) Indian Pharma Post Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The…...
Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials
1+ week, 5+ day ago (85+ words) indianpharmapost.com Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials The results build on statistically superior outcomes reported at Week 36, when the combination outperformed Taltz alone on key disease and metabolic measures Chasing Consistency: Centralizing operations…...
Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push
1+ week, 6+ day ago (65+ words) Merida's lead drug candidate, MER511, is already being tested in a Phase 1 trial for Graves' disease and thyroid eye disease Lilly to acquire Merida Biosciences for $2.875 billion in autoimmune disease push Sun Pharma joins White House push on US drug pricing…...
Teva bids $57.5 million upfront for BioXcel’s at-home schizophrenia, bipolar agitation drug
2+ week, 1+ day ago (62+ words) Envista launches Kerr Consumables in India, eyes growth in restorative and endodontic dentistry Tamil Nadu CM inaugurates world’s first Pinhole Pupilloplasty Centre at Dr Agarwal’s Eye Hospital South NeoCon 2026 advances newborn care across South India University of Toronto researchers develop…...
University of Toronto researchers develop tRNA approach to target genetic diseases
2+ week, 2+ day ago (652+ words) Engineered tRNA restores full-length protein production in cystic fibrosis models, opening the door to a potential new class of RNA therapeutics Researchers at the University of Toronto have developed a next-generation RNA therapeutic approach that could potentially treat a broad…...
Japan approves Bayer’s Hyrnuo for HER2-mutant lung cancer
2+ week, 6+ day ago (81+ words) Hyrnuo is the first targeted therapy approved in Japan for this indication that can be used regardless of the line of therapy AstraZeneca India receives ESG rating of 57 from CRISIL Pulnovo Medical enrolls first US patients in trial of PADN…...
AbbVie unveils new lung cancer data at 2026 WCLC
2+ week, 6+ day ago (86+ words) Indian Pharma Post AbbVie unveils new lung cancer data at 2026 WCLC AbbVie is also advancing telisotuzumab adizutecan (Temab-A), an investigational c-Met-directed ADC carrying a topoisomerase 1 inhibitor (Top1i) payload The Business of Genomics: Opportunities, Investments, and Innovation in India Chasing Consistency: Centralizing…...
FDA nod to Ultragenyx gene therapy for rare GSDIa disorder
3+ week, 1+ day ago (59+ words) GSDIa is caused by pathogenic variants in the G6PC gene NATCO Pharma’s Visakhapatnam facility receives 4 observations in US FDA inspection C2N Diagnostics’ PrecivityAD2 becomes first FDA-cleared Alzheimer’s blood test for adults aged 40+ SNEHA reports significant gains in child and maternal health across Mumbai’s…...